Inupadenant (EOS-850) 是一种具有口服活性的,高选择性 A2A 受体拮抗剂。Inupadenant 不能透过血脑屏障。Inupadenant 具有抗肿瘤活性。
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
Inupadenant is an orally active, highly selective A2A receptor antagonist. Inupadenant is not brain-penetrant. Inupadenant has potent anti-tumor activity[1].
[1]. Laurence Buisseret, et al. Phase 1 trial of the adenosine A2Areceptor antagonist inupadenant (EOS-850): Update on tolerability, and antitumor activity potentially associated with the expression of the A2A receptor within the tumor. Journal of Clinical Oncology. Volume 39, Issue 15_suppl.
5'-(N-Cyclopropyl)carboxamidoadenosine
¥670.00 ¥837.00
没有评价数据